Effect of fenbendazole on an autoimmune mouse model

Carolyn Cray, Toshiba Watson, Julia Zaias, Norman H. Altman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Fenbendazole is an anthelmintic drug widely used to treat and prevent pinworm infection in laboratory rodents. Data regarding possible side effects of fenbendazole on the immune system are conflicting, potentially due to the design of treatment protocols. The purpose of the current study was to determine the effects of 2 fenbendazole therapeutic regimens (continuous for 5 wk and alternating weeks [that is, 1 wk on, 1 wk off] for 9 wk) on the development of autoimmune disease in (NZB × NZW)F1 mice. No significant differences in survival curves or weight were observed between the treatment groups and cohort mice receiving nonmedicated feed. At the termination of the experiment, there were no differences in tissue pathology. Hematocrit decreased and BUN increased over time in all groups, but no significant differences were present between groups. After the cessation of treatment, mice fed the medicated diet continuously for 5 wk showed an increase in antiDNA antibody. Although this difference was significant, it did not affect survival curves or disease-related tissue or blood changes. These data indicate that common protocols of fenbendazole treatment do not alter the progression of autoimmune disease in (NZB × NZW)F1 mice.

Original languageEnglish
Pages (from-to)286-289
Number of pages4
JournalJournal of the American Association for Laboratory Animal Science
Volume52
Issue number3
StatePublished - May 1 2013

Fingerprint

fenbendazole
animal models
autoimmune diseases
mice
medicated feeds
anthelmintics
hematocrit
immune system
rodents
adverse effects
drugs
therapeutics
antibodies
blood
diet
infection
tissues

ASJC Scopus subject areas

  • Animal Science and Zoology

Cite this

Effect of fenbendazole on an autoimmune mouse model. / Cray, Carolyn; Watson, Toshiba; Zaias, Julia; Altman, Norman H.

In: Journal of the American Association for Laboratory Animal Science, Vol. 52, No. 3, 01.05.2013, p. 286-289.

Research output: Contribution to journalArticle

@article{6e7ccc7eba5141cca25ef31c4d030f84,
title = "Effect of fenbendazole on an autoimmune mouse model",
abstract = "Fenbendazole is an anthelmintic drug widely used to treat and prevent pinworm infection in laboratory rodents. Data regarding possible side effects of fenbendazole on the immune system are conflicting, potentially due to the design of treatment protocols. The purpose of the current study was to determine the effects of 2 fenbendazole therapeutic regimens (continuous for 5 wk and alternating weeks [that is, 1 wk on, 1 wk off] for 9 wk) on the development of autoimmune disease in (NZB × NZW)F1 mice. No significant differences in survival curves or weight were observed between the treatment groups and cohort mice receiving nonmedicated feed. At the termination of the experiment, there were no differences in tissue pathology. Hematocrit decreased and BUN increased over time in all groups, but no significant differences were present between groups. After the cessation of treatment, mice fed the medicated diet continuously for 5 wk showed an increase in antiDNA antibody. Although this difference was significant, it did not affect survival curves or disease-related tissue or blood changes. These data indicate that common protocols of fenbendazole treatment do not alter the progression of autoimmune disease in (NZB × NZW)F1 mice.",
author = "Carolyn Cray and Toshiba Watson and Julia Zaias and Altman, {Norman H.}",
year = "2013",
month = "5",
day = "1",
language = "English",
volume = "52",
pages = "286--289",
journal = "Journal of the American Association for Laboratory Animal Science",
issn = "1559-6109",
publisher = "American Association for Laboratory Animal Science",
number = "3",

}

TY - JOUR

T1 - Effect of fenbendazole on an autoimmune mouse model

AU - Cray, Carolyn

AU - Watson, Toshiba

AU - Zaias, Julia

AU - Altman, Norman H.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Fenbendazole is an anthelmintic drug widely used to treat and prevent pinworm infection in laboratory rodents. Data regarding possible side effects of fenbendazole on the immune system are conflicting, potentially due to the design of treatment protocols. The purpose of the current study was to determine the effects of 2 fenbendazole therapeutic regimens (continuous for 5 wk and alternating weeks [that is, 1 wk on, 1 wk off] for 9 wk) on the development of autoimmune disease in (NZB × NZW)F1 mice. No significant differences in survival curves or weight were observed between the treatment groups and cohort mice receiving nonmedicated feed. At the termination of the experiment, there were no differences in tissue pathology. Hematocrit decreased and BUN increased over time in all groups, but no significant differences were present between groups. After the cessation of treatment, mice fed the medicated diet continuously for 5 wk showed an increase in antiDNA antibody. Although this difference was significant, it did not affect survival curves or disease-related tissue or blood changes. These data indicate that common protocols of fenbendazole treatment do not alter the progression of autoimmune disease in (NZB × NZW)F1 mice.

AB - Fenbendazole is an anthelmintic drug widely used to treat and prevent pinworm infection in laboratory rodents. Data regarding possible side effects of fenbendazole on the immune system are conflicting, potentially due to the design of treatment protocols. The purpose of the current study was to determine the effects of 2 fenbendazole therapeutic regimens (continuous for 5 wk and alternating weeks [that is, 1 wk on, 1 wk off] for 9 wk) on the development of autoimmune disease in (NZB × NZW)F1 mice. No significant differences in survival curves or weight were observed between the treatment groups and cohort mice receiving nonmedicated feed. At the termination of the experiment, there were no differences in tissue pathology. Hematocrit decreased and BUN increased over time in all groups, but no significant differences were present between groups. After the cessation of treatment, mice fed the medicated diet continuously for 5 wk showed an increase in antiDNA antibody. Although this difference was significant, it did not affect survival curves or disease-related tissue or blood changes. These data indicate that common protocols of fenbendazole treatment do not alter the progression of autoimmune disease in (NZB × NZW)F1 mice.

UR - http://www.scopus.com/inward/record.url?scp=84877760365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877760365&partnerID=8YFLogxK

M3 - Article

C2 - 23849411

AN - SCOPUS:84877760365

VL - 52

SP - 286

EP - 289

JO - Journal of the American Association for Laboratory Animal Science

JF - Journal of the American Association for Laboratory Animal Science

SN - 1559-6109

IS - 3

ER -